BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 152419)

  • 1. [Immunopathological bases of the treatment of glomerulonephritis].
    Vercellone A; Segoloni G; Stratta P; Coppo R; Triolo G; Messina M
    Minerva Med; 1978 Aug; 69(38):2611-24. PubMed ID: 152419
    [No Abstract]   [Full Text] [Related]  

  • 2. Single and multiple drug therapy in autologous immune complex nephritis in rats.
    Kupor LR; Lowance DC; McPhaul JJ
    J Lab Clin Med; 1976 Jan; 87(1):27-36. PubMed ID: 128575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autologous immune complex glomerulonephritis with vasoactive amine antagonists.
    Garovoy MR; Kupor LR; Mullins JD; McPhaul JJ
    J Lab Clin Med; 1977 Oct; 90(4):638-44. PubMed ID: 143501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of the treatment of mesangiocapillary glomerulonephritis].
    Rodríguez JA; Olmos A; Ferrer E; Mauri JM; Capdevilla L; Codina S; Alsina J; Camps J; Piera L
    Rev Clin Esp; 1975 Dec; 139(5):415-22. PubMed ID: 1215585
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunomorphological profile of experimental glomerulonephritis treated with indocid].
    Vikhert AM; Megrelishvili RI; Ryff IM
    Patol Fiziol Eksp Ter; 1972; 16(5):62-5. PubMed ID: 4596809
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical treatment of glomerular diseases.
    Simon NM; Rosenberg MJ
    Med Clin North Am; 1978 Nov; 62(6):1157-81. PubMed ID: 153991
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of glomerulonephritis].
    Matthias S; Ritz E; Waldherr R
    Internist (Berl); 1995 Mar; 36(3):218-26. PubMed ID: 7737814
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic glomerulopathy].
    Orlowski T; Gradowska L; Lao M; Rancewicz Z; Rowinska D
    Z Gesamte Inn Med; 1972 Nov; 27(22):980-3. PubMed ID: 4649659
    [No Abstract]   [Full Text] [Related]  

  • 10. Glomerulonephritis--1974.
    Cameron JS
    Ir Med J; 1975 Jun; Suppl():73-80. PubMed ID: 241733
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of experimental immune complex nephritis with indomethacin].
    Hagemann I; Schneider W; Philipp H; Strangfeld D; Siewert H; Tietze G; Pietsch R
    Z Urol Nephrol; 1979 Jan; 72(1):49-58. PubMed ID: 154798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the effectiveness of diverse variants of drug therapy in chronic glomerulonephritis].
    Popova LA
    Ter Arkh; 1979; 51(1):77-83. PubMed ID: 432837
    [No Abstract]   [Full Text] [Related]  

  • 13. Regression of recurrent membranoproliferative glomerulonephritis type II in a transplanted kidney after plasmapheresis therapy.
    Oberkircher OR; Enama M; West JC; Campbell P; Moran J
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):418-23. PubMed ID: 2964750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of associated immunosuppressive -- antiphlogistic treatment of proliferative glomerulonephritis (author's transl)].
    Szewczyk Z; Szepietowski T; Falkiewicz K; Rabczyński J
    Przegl Lek; 1976; 33(5):550-4. PubMed ID: 948642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclosporin in treatment of glomerular diseases].
    Krieter DH; Müller GA
    Internist (Berl); 1996 Jan; 37(1):84-8. PubMed ID: 8837833
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pneumocystis carinii and aspergillus pneumonia in immunosuppression in rapidly progressing glomerulonephritis of the anti-glomerular basement membrane type].
    Späth M; Schollmeyer P
    Med Klin (Munich); 1996 Sep; 91(9):603-6. PubMed ID: 8984320
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple-drug therapy of chronic glomerulopathies.
    Orlowski T; Gradowska L; Lao M; Rowka D; Rancewicz Z
    Ateneo Parmense Acta Biomed; 1975; 46(5):481-90. PubMed ID: 822859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune deposits in generalised mesangioproliferative glomerulonephritis. Fluorescent microscopy findings correlated to symptoms, clinical course and immunosuppressive therapy.
    Larsen S
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):543-52. PubMed ID: 362810
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapse in anti glomerular basement membrane antibody mediated crescentic glomerulonephritis.
    Wu MJ; Moorthy AV; Beirne GJ
    Clin Nephrol; 1980 Feb; 13(2):97-102. PubMed ID: 7363520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current concepts of the drug therapy of glomerulonephritis].
    Müller V
    Z Urol Nephrol; 1981 Apr; 74(4):315-25. PubMed ID: 6455877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.